XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Accounts Payables (2020 - 2026)

Updated

XORTX Therapeutics (XRTX) recorded Accounts Payables of $678,522 in the quarter ended Jun 30, 2026, up 49.5% from $453,982 a year earlier but down 19.7% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Accounts Payables (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics reported Accounts Payables of $553,784, up 276.2% from the prior year.

  • Annual Accounts Payables has a five-year compound annual growth rate of -6.4% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Accounts Payables came in at $147,205 in the year ended Dec 31, 2024 (-48.1%), $283,428 in the year ended Dec 31, 2023 (-80.4%), $1.45 million in the year ended Dec 31, 2022 (+158.4%) and $559,366 in the year ended Dec 31, 2021 (-27.5%).
  • Quarterly Accounts Payables has ranged from $147,205 in the quarter ended Dec 31, 2024 to $1.44 million in the quarter ended Dec 31, 2022 over the past five years.
  • On a year-over-year basis, Accounts Payables has increased for six consecutive quarters, with growth averaging 60.2% over the last eight quarters.
  • Peak year-over-year performance for Accounts Payables in the last five years was growth of 276.2% in the quarter ended Dec 31, 2025, against a decline of 80.4% in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $844,932 (quarter ended Mar 31, 2026), $553,784 (quarter ended Dec 31, 2025) and $677,314 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 XORTX Therapeutics 1.61 Mn -1.69 Mn - 678,522.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 678,522.00
Mar 31, 2026 844,932.00
Dec 31, 2025 553,784.00
Sep 30, 2025 677,314.00
Jun 30, 2025 453,982.00
Mar 31, 2025 415,688.00
Dec 31, 2024 147,205.00
Sep 30, 2024 326,283.00
Jun 30, 2024 437,938.00
Mar 31, 2024 326,891.00
Dec 31, 2023 283,428.00
Sep 30, 2023 525,245.00
Jun 30, 2023 358,077.00
Mar 31, 2023 538,252.00
Dec 31, 2022 1.44 Mn
Sep 30, 2022 1.42 Mn
Jun 30, 2022 712,797.81
Mar 31, 2022 675,670.16
Dec 31, 2021 556,127.80
Sep 30, 2021 569,465.96
API Access

XORTX Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=XRTX&period=max&api_key=YOUR_API_KEY